Medispray Laboratories Private Limited

Produces pharmaceutical products.

1992 | Goa, Goa (India) | Active
Last Updated: December 29, 2024

Medispray Laboratories Profile

Key Indicators

  • Authorised Capital ₹ 5.10 Cr
  • Paid Up Capital ₹ 0.51 M
  • Company Age 32 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 0.18 M
  • Satisfied Charges ₹ 10.10 Cr
  • Revenue Growth 14.29%
  • Profit Growth 26.27%
  • Ebitda 14.82%
  • Net Worth -43.98%
  • Total Assets -36.25%

About Medispray Laboratories

Medispray Laboratories Private Limited (MLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 February 1992 and has a history of 32 years and 11 months. Its registered office is in Goa, Goa, India.

The Corporate was formerly known as Alpic Exports India Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.10 Cr and a paid-up capital of Rs 0.51 M.

The company currently has active open charges totaling ₹0.18 M. The company has closed loans amounting to ₹10.10 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Medispray Laboratories Private Limited India is Piyush Salot as CFO. Dinesh Jain, Anisha Udeshi, and Sanjay Mishra serve as directors at the Company.

Company Details

  • Location

    Goa, Goa, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U52311GA1992PTC002801

  • Company No.

    002801

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    21 Feb 1992

  • Date of AGM

    27 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Goa

Industry

Pharma

Who are the key members and board of directors at Medispray Laboratories?

Executive Team (2)

Name Designation Appointment Date Status
Sanjay Mishra Country flag representing In Managing Director 21-Oct-2022 Current
Piyush Salot CFO 22-Sep-2023 Current

Board Members (2)

Name Designation Appointment Date Status
Dinesh Jain Country flag representing In Director 14-Nov-2019 Current
Anisha Udeshi Country flag representing In Director 26-Aug-2021 Current

Financial Performance of Medispray Laboratories.

Medispray Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.29% increase. The company also saw a substantial improvement in profitability, with a 26.27% increase in profit. The company's net worth observed a substantial decline by a decrease of 43.98%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
14.29%
Revenue from Operations
11.90%
Total Assets
-36.25%
Profit or Loss
26.27%
Net Worth
-43.98%
EBITDA
14.82%

What is the Ownership and Shareholding Structure of Medispray Laboratories?

In 2021, Medispray Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0.02 Cr

Satisfied Charges

₹10.10 Cr

Charges Breakdown by Lending Institutions

  • Axis Bank Limited : 0.02 Cr

Latest Charge Details

Date Lender Amount Status
17 Mar 2023 Axis Bank Limited ₹0.08 M Open
17 Mar 2023 Axis Bank Limited ₹0.10 M Open
26 Apr 2016 The Hongkong And Shanghai Banking Corporation Limited ₹1.00 M Satisfied
05 Nov 2015 The Hongkong And Shanghai Banking Corporation Limited ₹10.00 Cr Satisfied

How Many Employees Work at Medispray Laboratories?

Medispray Laboratories has a workforce of 248 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medispray Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medispray Laboratories's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Medispray Laboratories

Recent activity within the organization

  • Annual General Meeting

    Medispray Laboratories Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.

    27 Sep 2024

  • Balance Sheet

    Medispray Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Goa.

    31 Mar 2024

  • Director Appointment

    Piyush Vadilal Salot was appointed as a Cfo was appointed as a Cfo on 22 Sep 2023 & has been associated with this company since 1 year 4 months .

    22 Sep 2023

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 0.01 Cr with Charge ID 100696431 was registered on 17 Mar 2023.

    17 Mar 2023

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 0.01 Cr with Charge ID 100696517 was registered on 17 Mar 2023.

    17 Mar 2023

  • Director Appointment

    Sanjay Kumar Mishra was appointed as a Managing Director was appointed as a Managing Director on 21 Oct 2022 & has been associated with this company since 2 years 3 months .

    21 Oct 2022

Frequently asked questions

  • Medispray Laboratories Private Limited was incorporated on 21 Feb 1992.

  • The authorized share capital of Medispray Laboratories Private Limited is ₹ 5.10 Cr and paid-up capital is ₹ 0.51 M.

  • Currently 4 directors are associated with Medispray Laboratories Private Limited.

    • Dinesh Ramniranjan Jain
    • Anisha Naresh Udeshi
    • Sanjay Kumar Mishra
    • Piyush Vadilal Salot
  • As per Ministry of Corporate Affairs (Mca), the registered address of Medispray Laboratories Private Limited is Plot No. 344/345 Kundaim Industrial Estate Kundaim, 403 115 India, Goa, 403115.

  • The corporate identification number (CIN) of Medispray Laboratories Private Limited is U52311GA1992PTC002801 and the company number is 002801 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2022, the revenue trend for Medispray Laboratories Private Limited has risen by 14.29%.

  • As Per 2022 financial reports, 248 employees are currently employed by Medispray Laboratories Private Limited.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Medispray Laboratories Private Limited has experienced an downturn of -43.98%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Medispray Laboratories Private Limited amount to ₹ 0.18 M.

  • The most recent Balance Sheet for Medispray Laboratories Private Limited was filed with the ROC on 31 Mar 2024.

Similar Companies Based on Drug Formulation & Development